Shuttle Pharmaceuticals Holdings (SHPH) Convertible Debt (2023 - 2025)

Shuttle Pharmaceuticals Holdings has reported Convertible Debt for 3 years, with the latest figure at $10.0 million in Q2 2025.

• On a quarterly basis, Convertible Debt changed 0.0% year-over-year to $10.0 million in Q2 2025; TTM through Jun 2025 was $10.0 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $10.0 million, up 7302.53% from the prior year.
• Convertible Debt was $10.0 million for Q2 2025 at Shuttle Pharmaceuticals Holdings, roughly flat from $10.0 million in the prior quarter.
• The five-year high for Convertible Debt was $10.0 million in Q2 2024, with the low at $122309.0 in Q2 2023.
• Average Convertible Debt over 3 years is $6.3 million, with a median of $10.0 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Convertible Debt soared 8076.01% in 2024, then changed 0.0% in 2025.
• Over 3 years, Convertible Debt stood at $135089.0 in 2023, then soared by 7302.53% to $10.0 million in 2024, then changed by 0.0% to $10.0 million in 2025.
• The last three Convertible Debt figures came in at $10.0 million (Q2 2025), $10.0 million (Q1 2025), and $10.0 million (Q4 2024), per Business Quant data.